|
Volumn 31, Issue 2, 2006, Pages 160-162
|
How we do it: Surgery should be considered equally with I131 and thionamide treatment as first-line therapy for thyrotoxicosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITHYROID AGENT;
CALCIUM;
IODINE 131;
LEVOTHYROXINE;
RADIOACTIVE IODINE;
THIONAMIDE;
VITAMIN D;
ADOLESCENT;
ADULT;
AGED;
AGRANULOCYTOSIS;
ARTHRALGIA;
ARTICLE;
CANCER;
CHROMOSOME DAMAGE;
DECISION MAKING;
DRUG FATALITY;
DRUG TREATMENT FAILURE;
ENDOCRINOLOGY;
EUROPE;
FEMALE;
FETUS DISEASE;
FEVER;
GASTROINTESTINAL SYMPTOM;
GENETIC DISORDER;
HEMATOMA;
HEPATITIS;
HUMAN;
HYPOCALCEMIA;
HYPOGLYCEMIA;
MAJOR CLINICAL STUDY;
MALE;
MALIGNANT NEOPLASTIC DISEASE;
NORTH AMERICA;
PAIN;
POSTOPERATIVE COMPLICATION;
PRIMARY HEALTH CARE;
PRIORITY JOURNAL;
PRURITUS;
RADIATION SICKNESS;
RASH;
RISK BENEFIT ANALYSIS;
SINGLE DRUG DOSE;
SORE THROAT;
SURGEON;
SWELLING;
THROMBOCYTOPENIA;
THYROIDECTOMY;
THYROIDITIS;
THYROTOXICOSIS;
ADOLESCENT;
ADULT;
AGED;
ANTITHYROID AGENTS;
FEMALE;
HUMANS;
IODINE RADIOISOTOPES;
MALE;
MIDDLE AGED;
THYROIDECTOMY;
THYROTOXICOSIS;
TREATMENT OUTCOME;
|
EID: 33645293207
PISSN: 17494478
EISSN: 17494486
Source Type: Journal
DOI: 10.1111/j.1749-4486.2006.01150.x Document Type: Article |
Times cited : (5)
|
References (8)
|